Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) has announced its upcoming first quarter 2025 financial results release and conference call schedule. The company will publish its Q1 2025 financial results press release on Wednesday, May 7, 2025, at 7:00 a.m. ET, followed by a conference call and live webcast at 8:00 a.m. ET the same day.
Interested participants must register in advance to obtain local or toll-free phone numbers and personal pins. The webcast will be accessible through Teva's investor relations website, with a replay available within 24 hours after the call conclusion.
Teva Pharmaceutical Industries (NYSE e TASE: TEVA) ha annunciato la prossima pubblicazione dei risultati finanziari del primo trimestre 2025 e il programma della conference call. L'azienda pubblicherà il comunicato stampa sui risultati finanziari del Q1 2025 mercoledì 7 maggio 2025, alle 7:00 a.m. ET, seguito da una conference call e webcast dal vivo alle 8:00 a.m. ET dello stesso giorno.
I partecipanti interessati devono registrarsi in anticipo per ottenere i numeri di telefono locali o gratuiti e i codici personali. Il webcast sarà accessibile tramite il sito web delle relazioni con gli investitori di Teva, con una registrazione disponibile entro 24 ore dalla conclusione della chiamata.
Teva Pharmaceutical Industries (NYSE y TASE: TEVA) ha anunciado la próxima publicación de los resultados financieros del primer trimestre de 2025 y el programa de la conferencia telefónica. La compañía publicará su comunicado de prensa sobre los resultados financieros del Q1 2025 el miércoles 7 de mayo de 2025, a las 7:00 a.m. ET, seguido de una conferencia telefónica y transmisión en vivo a las 8:00 a.m. ET del mismo día.
Los participantes interesados deben registrarse con anticipación para obtener números de teléfono locales o gratuitos y pines personales. La transmisión se podrá acceder a través del sitio web de relaciones con inversores de Teva, con una repetición disponible dentro de las 24 horas posteriores a la conclusión de la llamada.
테바 제약 산업 (NYSE 및 TASE: TEVA)는 2025년 1분기 재무 결과 발표 및 컨퍼런스 콜 일정을 발표했습니다. 회사는 2025년 5월 7일 수요일 오전 7:00 ET에 2025년 1분기 재무 결과 보도자료를 발표하며, 같은 날 오전 8:00 ET에 컨퍼런스 콜 및 실시간 웹캐스트를 진행합니다.
관심 있는 참가자는 사전 등록을 통해 지역 전화번호나 무료 전화번호 및 개인 핀번호를 받아야 합니다. 웹캐스트는 테바의 투자자 관계 웹사이트를 통해 접근 가능하며, 통화 종료 후 24시간 이내에 재생할 수 있습니다.
Teva Pharmaceutical Industries (NYSE et TASE : TEVA) a annoncé la prochaine publication de ses résultats financiers du premier trimestre 2025 ainsi que le programme de la conférence téléphonique. L'entreprise publiera son communiqué de presse sur les résultats financiers du T1 2025 le mercredi 7 mai 2025 à 7h00 ET, suivi d'une conférence téléphonique et d'une diffusion en direct à 8h00 ET le même jour.
Les participants intéressés doivent s'inscrire à l'avance pour obtenir des numéros de téléphone locaux ou gratuits et des codes personnels. La diffusion sera accessible via le site web des relations investisseurs de Teva, avec une rediffusion disponible dans les 24 heures suivant la fin de l'appel.
Teva Pharmaceutical Industries (NYSE und TASE: TEVA) hat die bevorstehende Veröffentlichung der Finanzzahlen für das erste Quartal 2025 sowie den Zeitplan für die Telefonkonferenz bekannt gegeben. Das Unternehmen wird am Mittwoch, den 7. Mai 2025, um 7:00 Uhr ET die Pressemitteilung zu den Finanzzahlen für das Q1 2025 veröffentlichen, gefolgt von einer Telefonkonferenz und einem Live-Webcast um 8:00 Uhr ET am selben Tag.
Interessierte Teilnehmer müssen sich im Voraus registrieren, um lokale oder gebührenfreie Telefonnummern und persönliche PINs zu erhalten. Der Webcast wird über die Website der Investor Relations von Teva zugänglich sein, mit einer Wiederholung, die innerhalb von 24 Stunden nach dem Ende des Anrufs verfügbar ist.
- None.
- None.
TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2025 financial results on Wednesday, May 7, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.
In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations.
Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to deliver medicines to patients worldwide. For over 120 years, Teva’s commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients’ needs, now and in the future. Moving forward together with science that treats, inspired by the people we serve. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Risk Factors” and "Forward-looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
FAQ
When will Teva (TEVA) release its Q1 2025 financial results?
How can investors join Teva's Q1 2025 earnings call?
What time is Teva's Q1 2025 earnings conference call?
Where can I find the replay of Teva's Q1 2025 earnings call?
